Pfizer To Settle FCPA Bribery Probe For $60M
Pharmaceutical giant Pfizer Inc. will reportedly pay more than $60 million under deals with U.S. regulators to settle investigations into whether it used bribes to secure business in foreign countries....To view the full article, register now.
Already a subscriber? Click here to view full article